tiprankstipranks
Trending News
More News >
Argent Biopharma (AU:RGT)
ASX:RGT
Australian Market
Advertisement

Argent Biopharma (RGT) Technical Analysis

Compare
6 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Argent Biopharma’s (RGT) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Argent Biopharma is a Sell.
Argent Biopharma’s (RGT) 20-Day exponential moving average is 0.08, while Argent Biopharma’s (RGT) share price is <AU$0.1, making it a Sell.
Argent Biopharma’s (RGT) 50-Day exponential moving average is 0.09, while Argent Biopharma’s (RGT) share price is <AU$0.1, making it a Sell.

Argent Biopharma (RGT) Pivot Points

Jul 29, 2025, 01:16 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.08
0.08
0.08
0.08
0.08
0.08
Fibonacci
0.08
0.08
0.08
0.08
0.08
0.08
0.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Argent Biopharma (RGT) Moving Averages

Jul 29, 2025, 01:16 AM
Period
Simple
Exponential
MA5
0.08Sell
0.08Sell
MA10
0.08Sell
0.08Sell
MA20
0.08Sell
0.08Sell
MA50
0.09Sell
0.09Sell
MA100
0.12Sell
0.12Sell
MA200
0.18Sell
0.18Sell
Argent Biopharma’s (RGT) 10-Day exponential moving average is 0.08, while Argent Biopharma’s (RGT) share price is <AU$0.1, making it a Sell.
Argent Biopharma’s (RGT) 100-Day exponential moving average is 0.12, while Argent Biopharma’s (RGT) share price is <AU$0.1, making it a Sell.
Argent Biopharma’s (RGT) stock price is <AU$0.1 and Argent Biopharma’s (RGT) 50-day simple moving average is 0.09, creating a Sell signal.
Argent Biopharma’s (RGT) stock price is <AU$0.1 and Argent Biopharma’s (RGT) 100-day simple moving average is 0.12, creating a Sell signal.
Argent Biopharma’s (RGT) stock price is <AU$0.1 and Argent Biopharma’s (RGT) 200-day simple moving average is 0.18, creating a Sell signal.

Argent Biopharma (RGT) Technical Indicators

Jul 29, 2025, 01:16 AM
Name
Value
Implied Action
RSI (14)
43.26
Neutral
STOCH (9,6)
8.89
Buy
STOCHRSI (14)
8.89
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
10.07
Buy
Williams %R
-73.33
Buy
CCI (14)
-121.90
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
59.08
Neutral
ROC
-8.14
Sell
Argent Biopharma’s (RGT) Relative Strength Index (RSI) is 43.26, creating a Neutral signal.
Argent Biopharma’s (RGT) Trend Strength Indicator (ADX) is 10.07, creating a Buy signal.
Argent Biopharma’s (RGT) Commodity Channel Index (CCI) is -121.90, creating a Buy signal.
Argent Biopharma’s (RGT) Price Rate of Change (ROC) is -8.14, creating a Sell signal.

FAQ

Is RGT a Buy, Hold, or Sell?
Based on RGT’s technical indicators, RGT is a Sell.
    What is RGT’s RSI (14)?
    RGT’s RSI (14) is 43.26, which suggests RGT is a Neutral.
      What is RGT’s MACD?
      RGT’s MACD is >-0.01, which suggests RGT is a Sell.
        What is RGT’s 5-day moving average?
        RGT’s 5-day moving average is 0.08, which suggests RGT is a Sell.
          What is RGT’s 20-day moving average?
          RGT 20-day moving average is 0.08, which suggests RGT is a Sell.
            What is RGT’s 50-day moving average?
            RGT’s 50-day moving average is 0.09, which suggests RGT is a Sell.
              What is RGT’s 200-day moving average?
              RGT’s 200-day moving average is 0.18, which suggests RGT is a Sell.
                What is RGT’s Williams % R (14)?
                RGT’s Williams % R (14) is -73.33, which suggests RGT is a Buy.
                  What is RGT’s CCI (14)?
                  RGT’s CCI (14) is -121.90, which suggests RGT is a Buy.
                    What is the share price of Argent Biopharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis